1 month Verrica Pharmaceuticals (NASDAQ:VRCA) Given New $10.00 Price Target at TD CowenMarketBeat
TD Cowen cut their target price on Verrica Pharmaceuticals from $15.00 to $10.00 and set a “buy” rating on the stock in a research note on Monday.
Nasdaq 100 · Pharmaceuticals · Science
X